这些降价使 Ola 的估值降至约 26.5 亿美元，PharmEasy 的估值降至约 5.5 亿美元。
50 个字：投资者大幅削减 Ola 和 PharmEasy 股份的价值
Date:
About
FigureAsia (ISSN: 3005-3978) is a premier international magazine dedicated to in-depth coverage of Asia. It offers authoritative analysis and reportage across critical domains, including politics, economics, society, culture, and technology. FigureAsia serves as a distinguished platform, delivering nuanced insights and comprehensive perspectives to an informed Asian readership, with a focus on both regional dynamics and global trends.
Magazine
News
FDA proposes new test to detect asbestos in cosmetics and other products containing talc
Manufacturers of baby powder and cosmetics made with talc...
Iran's energy crisis intensifies, industries shut down
According to the New York Times, Iran is...
Chinese battery giant CATL plans to list in Hong Kong
Chinese battery maker Contemporary Amperex Technology Co Ltd...
Subscribe
© 2024 FigureAsia Publishing Group Limited All Rights Reserved.
Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information | Ad Choices
FigureAsia may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
ISSN: 3005-3978 is the property of FigureAsia. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.